Hospital bidding prices should be readjusted, KPMA says

The Korea Pharmaceutical Manufacturers Association said the controversial hospital bidding drug prices should be controlled under the actually traded pricing system to prevent dual pricing of a same drug in hospital tender.

It argued pharmaceutical companies have no choice but to provide a certain portion of low-priced medical supplies to the hospitals in return for buying supplies.

Meant...